New investors of which Capitole Angels and independant investors have joined historic funders in a fund raising of 607k€.

These financial resources will be used to implement production process and finalize first applications of which DendrisChips “respiratory diagnosis” and “Sexual transmitable diagnosis”.

 

 

 .